Summary
David Keener is a Ph.D. candidate at UMass Medical School with 11 years of experience at the intersection of CRISPR/Cas9 and RNA therapeutics, currently developing prime editing approaches and RNA bio-orthogonal chemistries for Rett syndrome research. He brings hands-on molecular and cellular expertise—from single-cell electroporation in neurons to microbiology and formulation chemistry—paired with systems engineering and data-analysis skills. His background spans academic labs and biotech, including DARPA-directed biocement work and antimicrobial drug screening, demonstrating adaptability across diverse experimental platforms. David also communicates science to broader audiences as co-creator and co-host of The Harry Podcast, showing an unusual blend of rigorous research and public engagement. Comfortable with experimental design, method development, and scientific writing, he excels at turning complex protocols into reproducible workflows. Based in Worcester, he leverages interdisciplinary training to translate molecular tools into therapeutic and translational outcomes.
10 years of coding experience
3 years of employment as a software developer
Bachelor of Science - BS, Neuroscience, 3.69, Bachelor of Science - BS, Neuroscience, 3.69 at University of Rochester